Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.42 |
| ▸ | NPY1R | P25929 | 6/20 | 0.42 |
| ▸ | NPY2R | P49146 | 4/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.37 |
| ▸ | ANPEP | P15144 | 2/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.36 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.36 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.35 |
| ▸ | OTC | P00480 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17459883 | 1.00 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL1406051 | 0.90 | NPY4R (0.39) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL18877225 | 0.86 | NPY4R (0.36) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL2899157 | 0.85 | OTC (0.43) | NPY4RNPY1RDPP7DDAH1OTC | |
| SCHEMBL9330200 | 0.84 | DPP7 (0.42) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL93607 | 0.84 | DPP7 (0.42) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL93606 | 0.84 | DPP7 (0.42) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL157856 | 0.84 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL2172217 | 0.84 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL42488 | 0.84 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9993490-B2 | Phosphonic acid compounds and screening method | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2018-06-12 | — | — | US | disclosed |
| US-20170202863-A1 | PHOSPHONIC ACID COMPOUNDS AND SCREENING METHOD | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2017-07-20 | — | — | US | disclosed |
| WO-2016014539-A1 | PHOSPHONIC ACID COMPOUNDS AND SCREENING METHOD | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2016-01-28 | — | — | WO | disclosed |
| CN-101415641-B | Modified clay mineral | AJINOMOTO CO.,INC. (JP) | 2012-02-08 | — | — | CN | disclosed |
| CN-101415641-A | Modified clay mineral | AJINOMOTO KK (JP) | 2009-04-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202863-A1 | PHOSPHONIC ACID COMPOUNDS AND SCREENING METHOD | BPGM, PGM2, PPA1 | NPY4R 4848/4885NPY1R 4691/4885NPY2R 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.